The most effective melasma treatment in the evidence is triple combination cream, which pairs hydroquinone, tretinoin and a corticosteroid, with hydroquinone alone next.1 TRI-LUMA, the FDA-approved triple cream, is labeled for short-term treatment of moderate to severe facial melasma alongside sun protection.2 Tretinoin, azelaic acid, visible-light sunscreen and oral tranexamic acid add further options. Melasma often returns after treatment stops, so your physician plans for maintenance from the first visit.2,3
Melasma and the Two-Phase Treatment Plan
Melasma is an acquired, chronic pigment disorder that causes darker patches, usually on the face. It predominantly affects women.1 A 2022 systematic review puts its prevalence between 8.8% and 40%, depending on ethnicity and geography, and notes it is common in people with darker skin types.3
No single treatment works for everyone, and recurrence rates stay high across every treatment group.3 Your plan will likely change as your skin responds. Combinations of two or three agents gave the best results.3 The reviewers recommend choosing treatment after a Wood's lamp and dermatoscope exam, so treatment matches each melasma subtype.3 If your physician cannot do that exam by video, an in-person skin exam can feed into the same plan.
If you have melasma, plan for two phases: clearing the patches, then keeping them from returning. Your physician builds both into the plan from the start.
Triple Combination Cream and Hydroquinone
Hydroquinone is a melanin synthesis inhibitor, meaning it slows the production of skin pigment.2 A 2022 review calls it "the gold standard in melasma treatment."3 Triple combination cream adds tretinoin (a retinoid) and a corticosteroid.2
TRI-LUMA combines fluocinolone acetonide (a corticosteroid), hydroquinone and tretinoin. It is indicated for "the short-term treatment of moderate to severe melasma of the face," used with sun avoidance and sunscreen.2 Its approval rests on two 8-week trials of 641 adults with skin types I to IV, about 98% of them women.2
The primary outcome was clearing, meaning patches matched the surrounding skin. In the first trial, 38% cleared on TRI-LUMA compared with 15%, 0% and 4% on the three two-ingredient versions. In the second trial, the figures were 13% against 4%, 4% and 1%.2 A Cochrane review found triple combination cream more effective at lightening melasma than hydroquinone alone.4
The label sets clear limits. TRI-LUMA is not indicated for maintenance, and melasma usually recurs after stopping it.2 It has not been studied in skin types V and VI, and the label notes that excessive bleaching in darker skin cannot be excluded.2 A 2021 network meta-analysis of 59 randomized trials still rated triple combination cream the most favorable topical choice once both efficacy and safety were counted.5
If your melasma is moderate to severe, a short course of triple cream is the best-supported start. Once the patches are controlled, the label allows a move to other treatments for maintenance, and your physician plans that step with you.2
Tretinoin and Azelaic Acid
Tretinoin alone has a smaller evidence base for melasma, and it had the lowest side-effect rate in one network meta-analysis, at 10.1%.5 In two placebo-controlled trials reviewed by Cochrane, objective measures showed reduced severity with tretinoin in both, and participants rated their melasma improved in one.4 The tretinoin page covers its label cautions, which apply to any reader.
Azelaic acid has head-to-head data against hydroquinone. Cochrane found 20% azelaic acid more effective than 2% hydroquinone, with no difference against 4% hydroquinone.4 In a 24-week double-blind trial of 329 women, 65% had good or excellent results on azelaic acid, with no difference from 4% hydroquinone. No allergic sensitization or exogenous ochronosis was seen with azelaic acid.6
These two agents give your physician options when hydroquinone is a poor fit for you, and the TRI-LUMA label allows other treatments once control is achieved.2
Sun and Visible-Light Protection
Every melasma treatment approach includes broad-spectrum sunscreen, according to the authors of a 2014 randomized trial.7 The TRI-LUMA label makes sun avoidance and sunscreen a condition of its indication.2 Visible light also matters. A randomized trial notes that visible light can cause pigment changes similar to ultraviolet light in darker-skinned patients.7
That trial gave 68 melasma patients 4% hydroquinone plus one of two SPF 50 or higher sunscreens for 8 weeks. One sunscreen contained iron oxide, a pigment that absorbs visible light, and the other blocked ultraviolet only.7 The iron-oxide group improved 15% more on melasma severity scores and 28% more on skin color measurement.7
A tinted sunscreen with iron oxide is a practical choice to discuss with your physician, especially if your skin is darker or you spend long hours outdoors.
Oral Tranexamic Acid and Procedures
Oral tranexamic acid is a newer option. A 2020 evidence review calls it "a promising new treatment for moderate and severe recurrent melasma," while noting that long-term safety and efficacy need more study.1 A meta-analysis of 11 tranexamic acid studies and 667 participants found that adding it to standard treatment lowered melasma severity scores further. Side effects were minor, including lighter periods, mild stomach upset and skin irritation.8 A 2022 systematic review notes the systemic treatment was linked to systemic side effects.3
Tranexamic acid tablets are FDA-labeled for cyclic heavy menstrual bleeding, so melasma use falls outside the label.9 The label contraindicates them with combined hormonal contraceptives and in anyone with a history or high risk of blood clots.9 If your physician raises this option, your full medication list and clot history decide whether it is safe for you.
Chemical peels, lasers and light devices have mixed results. The 2020 review found them equal or inferior to topical treatment, with a higher risk of side effects.1 If you choose a procedure, expect recurrence to stay high after it as well.3 For most people, topical treatment and sun protection stay the foundation of the plan.1
Side Effects Your Physician Monitors
If you start treatment, the side effects you are most likely to notice are mild, mainly irritation, dryness, burning, redness and post-inflammatory darkening.1 In the TRI-LUMA trials, 63% had at least one treatment-related side effect, most often redness (41%) and peeling (38%), and most were mild to moderate.2
Three label warnings shape your physician's choices:
- Exogenous ochronosis. Hydroquinone may cause a gradual blue-black darkening of the skin, which should prompt stopping treatment. Most reported cases have been in Black patients.2
- Corticosteroid effects. The steroid in triple cream can be absorbed and suppress the body's own stress-hormone axis, which reverses after stopping.2
- Pregnancy. TRI-LUMA contains tretinoin, a known teratogen, and should be used in pregnancy only if the benefit justifies the risk.2
The label also directs that therapy stop once control is achieved.2 Tell your physician if you are pregnant or planning to be, so the plan can use options that fit.
Melasma and Thyroid Markers
Some evidence links melasma to thyroid markers. A meta-analysis of seven studies with 473 melasma patients and 379 controls found higher TSH, anti-TPO and antithyroglobulin antibody levels in people with melasma. The differences were larger among women.10
The authors describe the thyroid link as still controversial, and the data are observational.10 It still gives your physician a reason to check thyroid markers alongside your skin, especially if you have fatigue or other symptoms that fit.
The Opt Take on Melasma Treatment
Melasma responds to treatment and tends to return, which makes it a condition you manage over time with a physician. The Opt Health membership repeats labs and a physician consultation every 3 to 4 months. Your initial panel covers 55+ biomarkers, including hormone markers, at home or at a partner lab. A 1:1 physician review then reads your results against your skin, your symptoms and your goals.
Existing conditions and current medications are reviewed at that first consultation. That is the point to raise contraceptives and any clot history, before tranexamic acid is ever discussed. Prescriptions ship from our pharmacy to your home. At each repeat consultation, your plan can shift from clearing to maintenance on what your skin and labs show. A women's health track is available for menopause-related care. If your concern is thinning or fine lines, estriol face cream covers a different set of evidence.
Get started: Begin with Opt Health, where a physician reads your labs, builds your plan, and adjusts it over the loop.
Frequently Asked Questions
Melasma cream is a topical treatment that lightens melasma patches, usually by slowing melanin production. The best-studied options are triple combination cream and hydroquinone.1 TRI-LUMA is the FDA-approved triple cream, combining hydroquinone, tretinoin and a corticosteroid.2 Your physician chooses the cream from the severity of your melasma and your skin type.
Triple combination cream and hydroquinone have the strongest evidence.1 Azelaic acid matched 4% hydroquinone in trials, and tretinoin reduced melasma severity against placebo.4,6 A sunscreen with iron oxide improved results more than a UV-only sunscreen when both were used with hydroquinone.7 Your physician often combines two or more, since combinations performed best.3
Prescription melasma creams are effective for many people, though few clear completely. In the TRI-LUMA trials, 38% and 13% of participants cleared at 8 weeks, well ahead of two-ingredient versions.2 Recurrence is common after stopping, so your results depend on sun protection and a maintenance plan.2,3
TRI-LUMA is FDA-approved for the short-term treatment of moderate to severe facial melasma, used with sun protection.2 It is not approved for maintenance treatment.2 For any other product, ask your physician what it contains and whether it carries an FDA approval before you use it.
Hydroquinone bleaching cream is one of the most effective melasma treatments, and the darkening it can cause is a different condition, exogenous ochronosis.1,2 Hydroquinone may cause exogenous ochronosis, a gradual blue-black darkening of the skin, and that change calls for stopping treatment.2 Darker patches during treatment are worth showing to your physician promptly.
Melasma tends to return, so it needs a plan that is reviewed over time. An Opt Health membership starts with 55+ biomarkers and a 1:1 physician review, then repeats labs and a physician consultation every 3 to 4 months.
References
- McKesey J et al. Melasma treatment: an evidence-based review. Am J Clin Dermatol. 2020;21(2):173-225. https://pubmed.ncbi.nlm.nih.gov/31802394/
- Galderma Laboratories, L.P. TRI-LUMA (fluocinolone acetonide, hydroquinone, and tretinoin) cream [prescribing information]. DailyMed. Published October 28, 2024. Accessed October 14, 2026. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=a35fa709-5eb5-4429-b38f-f1e0019bf0ee
- Neagu N et al. Melasma treatment: a systematic review. J Dermatolog Treat. 2022;33(4):1816-1837. https://pubmed.ncbi.nlm.nih.gov/33849384/
- Rajaratnam R et al. Interventions for melasma. Cochrane Database Syst Rev. 2010;2010(7):CD003583. https://pubmed.ncbi.nlm.nih.gov/20614435/
- Liu Y et al. Comparison of the efficacy of melasma treatments: a network meta-analysis of randomized controlled trials. Front Med (Lausanne). 2021;8:713554. https://pubmed.ncbi.nlm.nih.gov/34660626/
- Baliña LM et al. The treatment of melasma: 20% azelaic acid versus 4% hydroquinone cream. Int J Dermatol. 1991;30(12):893-895. https://pubmed.ncbi.nlm.nih.gov/1816137/
- Castanedo-Cazares JP et al. Near-visible light and UV photoprotection in the treatment of melasma: a double-blind randomized trial. Photodermatol Photoimmunol Photomed. 2014;30(1):35-42. https://pubmed.ncbi.nlm.nih.gov/24313385/
- Kim HJ et al. Efficacy and safety of tranexamic acid in melasma: a meta-analysis and systematic review. Acta Derm Venereol. 2017;97(7):776-781. https://pubmed.ncbi.nlm.nih.gov/28374042/
- Northstar Rx LLC. Tranexamic acid tablets [prescribing information]. DailyMed. Published August 3, 2026. Accessed October 14, 2026. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=4877eacd-fda7-4708-93a5-81052c1d2e14
- Kheradmand M et al. Melasma and thyroid disorders: a systematic review and meta-analysis. Int J Dermatol. 2019;58(11):1231-1238. https://pubmed.ncbi.nlm.nih.gov/31149743/
This content is for informational purposes and does not replace evaluation, diagnosis, or treatment by a qualified medical professional.
This article is part of our guide to skin health. See the Opt Health radiant skin protocol.
Start Today
Your health, your terms. Discover how personalized care can transform not just the way you feel, but how you live.